✦ LIBER ✦

Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C

✍ Scribed by Tommaso Maria Manzia; Roberta Angelico; Luca Toti; Maria Irene Bellini; Daniele Sforza; Giampiero Palmieri; Giuseppe Orlando; Laura Tariciotti; Mario Angelico; Giuseppe Tisone

Book ID: 110917559
Publisher: Springer
Year: 2011
Tongue: English
Weight: 317 KB
Volume: 24
Category: Article
ISSN: 0934-0874
DOI: 10.1111/j.1432-2277.2011.01228.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maintenance ribavirin monotherapy delays

Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression

✍ Raffaella Lionetti; Giuseppe Tisone; Giampiero Palmieri; Cristiana Almerighi; Al 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 153 KB

144 Long-term ribavirin monotherapy sign

144 Long-term ribavirin monotherapy significantly delays fibrosis progression in OLT recipients with recurrent hepatitis C

✍ R. Lionetti; G. Palmieri; S. Battista; A. Petrolati; D. Di Paolo; C. Ciceroni; L 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 77 KB

One-year protocol liver biopsy can strat

One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection

✍ Roberto J. Firpi; Manal F. Abdelmalek; Consuelo Soldevila-Pico; Roniel Cabrera; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

Determinants of progression to cirrhosis in hepatitis C virus (HCV) infection have been well described in the immunocompetent population but remain poorly defined in liver transplant (LT) recipients. This cohort study determines the factors contributing to the development of fibrosis and its rate of

Occult hepatitis B virus infection in li

Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression

✍ Pierluigi Toniutto; Rosalba Minisini; Carlo Fabris; Tullia De Feo; Francesca Mar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

The long-term effects of immune suppress

The long-term effects of immune suppression on liver transplant recipients with recurrent hepatitis C viral infection

✍ G.W. Neff; J. delaGarza; N. Shire; S. Nishida; C.B. O'Brien; K. Safdar; J. Madar 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Factors influencing the progression of f

Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: A retrospective analysis of 939 liver biopsies in a single center

✍ Thomas Walter; Jérôme Dumortier; Olivier Guillaud; Valérie Hervieu; Jean-Yves Sc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

Recurrent hepatitis C after liver transplantation (LT) is a major problem, since up to 30% of patients develop cirrhosis only 5 years after LT in the absence of antiviral therapy. The aim of this study was to examine the rate of progression of fibrosis and its associated risk factors in patients sub